Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description

IF 2.7 2区 医学 Q2 UROLOGY & NEPHROLOGY Prostate International Pub Date : 2022-06-01 DOI:10.1016/j.prnil.2021.10.003
Tae Il Noh, Jong Hyun Tae, Ji Sung Shim, Seok Ho Kang, Jun Cheon, Jeong Gu Lee, Sung Gu Kang
{"title":"Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description","authors":"Tae Il Noh,&nbsp;Jong Hyun Tae,&nbsp;Ji Sung Shim,&nbsp;Seok Ho Kang,&nbsp;Jun Cheon,&nbsp;Jeong Gu Lee,&nbsp;Sung Gu Kang","doi":"10.1016/j.prnil.2021.10.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>With the implementation of da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA), we described our initial experience with the da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA) for single-port robotic-assisted radical prostatectomy (SP-RARP).</p></div><div><h3>Methods</h3><p>This retrospective review included 30 consecutive patients with prostate biopsy-confirmed prostate cancer who underwent SP-RARP by a single surgeon between June and November 2020. SP-RARP was performed with a single-incision plus one method, in which the multichannel guide port was inserted directly with an additional assist port. We report our initial experience of perioperative and early functional outcomes.</p></div><div><h3>Results</h3><p>The mean operative time (SD), console time (SD), and blood loss were 142.8 (15.1) min, 109.9 (15.7) min, and 133.0 (72.9) mL, respectively. No intraoperative complications or blood transfusions were reported. Of the 30 patients, 21 (70.0%), 7 (23.3%) and 2 (6.7%) had stage pT2, pT3a and pT3b disease, respectively. Positive surgical margins were reported in 5 of the 30 (16.7%) patients in the final pathology report, including 2 of 21 (9.5%) with stage pT2 and 3 of 9 (33.3%) with ≥ pT3. At 12 weeks after SP-RARP, 80.0% of patients had achieved continence and the potency was 46.7%; 8 of 11 (72.7%) had sexual health inventory for men (SHIM) scores ≥ 17 and 6 of 19 (31.6%) had SHIM scores &lt; 17.</p></div><div><h3>Conclusions</h3><p>The SP platform for radical prostatectomy was technically safe and feasible. After overcoming the technical learning curve, this platform may provide high-quality outcomes comparable to those of multi-port platforms.</p></div>","PeriodicalId":20845,"journal":{"name":"Prostate International","volume":"10 2","pages":"Pages 85-91"},"PeriodicalIF":2.7000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2287888221000581/pdfft?md5=d611436f8e9ec72b70346ba5278bb2eb&pid=1-s2.0-S2287888221000581-main.pdf","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostate International","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2287888221000581","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 6

Abstract

Background

With the implementation of da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA), we described our initial experience with the da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA) for single-port robotic-assisted radical prostatectomy (SP-RARP).

Methods

This retrospective review included 30 consecutive patients with prostate biopsy-confirmed prostate cancer who underwent SP-RARP by a single surgeon between June and November 2020. SP-RARP was performed with a single-incision plus one method, in which the multichannel guide port was inserted directly with an additional assist port. We report our initial experience of perioperative and early functional outcomes.

Results

The mean operative time (SD), console time (SD), and blood loss were 142.8 (15.1) min, 109.9 (15.7) min, and 133.0 (72.9) mL, respectively. No intraoperative complications or blood transfusions were reported. Of the 30 patients, 21 (70.0%), 7 (23.3%) and 2 (6.7%) had stage pT2, pT3a and pT3b disease, respectively. Positive surgical margins were reported in 5 of the 30 (16.7%) patients in the final pathology report, including 2 of 21 (9.5%) with stage pT2 and 3 of 9 (33.3%) with ≥ pT3. At 12 weeks after SP-RARP, 80.0% of patients had achieved continence and the potency was 46.7%; 8 of 11 (72.7%) had sexual health inventory for men (SHIM) scores ≥ 17 and 6 of 19 (31.6%) had SHIM scores < 17.

Conclusions

The SP platform for radical prostatectomy was technically safe and feasible. After overcoming the technical learning curve, this platform may provide high-quality outcomes comparable to those of multi-port platforms.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
单端口机器人辅助前列腺根治术的初步经验:一位外科医生的经验与技术描述
随着达芬奇SP机器人平台(Intuitive Surgical, Inc., Sunnyvale, CA, USA)的实施,我们描述了我们使用达芬奇SP机器人平台(Intuitive Surgical, Inc., Sunnyvale, CA, USA)进行单端口机器人辅助根治性前列腺切除术(SP- rarp)的初步经验。方法本回顾性研究包括30例连续的前列腺活检确诊的前列腺癌患者,这些患者在2020年6月至11月期间由一名外科医生接受了SP-RARP。SP-RARP采用单切口加一方法,其中多通道引导端口直接插入额外的辅助端口。我们报告围手术期和早期功能结果的初步经验。结果平均手术时间(SD)为142.8 (15.1)min,镇静时间(SD)为109.9 (15.7)min,出血量为133.0 (72.9)mL。无术中并发症及输血。30例患者中,pT2期21例(70.0%),pT3a期7例(23.3%),pT3b期2例(6.7%)。最终病理报告的30例患者中有5例(16.7%)报告手术切缘阳性,其中pT2期21例中有2例(9.5%),pT3≥9例中有3例(33.3%)。SP-RARP治疗12周后,80.0%的患者实现了尿失禁,效价为46.7%;11人中有8人(72.7%)的男性性健康量表(SHIM)得分≥17分,19人中有6人(31.6%)的SHIM得分为<17.结论SP平台在根治性前列腺切除术中技术安全可行。在克服了技术学习曲线后,该平台可以提供与多端口平台相当的高质量结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Prostate International
Prostate International Medicine-Urology
CiteScore
4.40
自引率
26.70%
发文量
40
审稿时长
35 days
期刊介绍: Prostate International (Prostate Int, PI), the official English-language journal of Asian Pacific Prostate Society (APPS), is an international peer-reviewed academic journal dedicated to basic and clinical studies on prostate cancer, benign prostatic hyperplasia, prostatitis, and ...
期刊最新文献
Corrigendum to “Screening and validation of novel serum panel of microRNA in stratification of prostate cancer” [Prostate Int 11 (2023) 150–158] Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - An ambispective study Utility of transperineal template-guided mapping prostate biopsy in biopsy-naïve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging The association between inflammatory bowel disease and risk of prostate cancer: a population-based retrospective study based on Korean National Health Insurance Service database
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1